On December 27, E Fund CSI 300 Pharmaceutical ETF (512010) closed down 0.27%, with a turnover of 539 million yuan.
Pharmaceutical ETF (512010) was established on September 23, 2013, and the full name of the fund is E Fund CSI 300 Medical and Health Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as E Fund CSI 300 Pharmaceutical ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the pharmaceutical ETF (512010) is based on the CSI 300 Medical and Health Index.
In terms of scale, as of December 26, the latest share of pharmaceutical ETF (512010) was 64.136 billion shares, and the latest scale was 23.467 billion yuan. Looking back on December 29, 2023, the share of pharmaceutical ETF (512010) was 49.656 billion shares, with a scale of 20.433 billion yuan. That is, the share of the fund has increased by 29.16% and the scale has increased by 14.85% since the beginning of this year.
In terms of liquidity, as of December 27, the cumulative turnover of pharmaceutical ETF (512010) in the past 20 trading days was 12.477 billion yuan, with an average daily turnover of 624 million yuan, and since the beginning of this year, the cumulative turnover in 240 trading days has been 135.184 billion yuan, with an average daily turnover of 563 million yuan.
The current fund manager of the Pharmaceutical ETF (512010) is Yu Haiyan. Yu Haiyan has managed (or intends to manage) the fund since September 23, 2013, and has returned 46.36% during her tenure.
According to the latest regular report, the heavy stocks of pharmaceutical ETF (512010) include Hengrui Pharmaceutical, Mindray Medical, WuXi AppTec, Pien Tze Huang, Aier Ophthalmology, Yunnan Baiyao, United Imaging Medical, Shanghai RAAS, Xinhecheng, and Zhifei Biotech, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 600276 | Hengrui Pharmaceutical | : 16.89%, | 69.7269 thousand | , 3.647 billion |
| , 300760 | ,Mindray Medical | , 12.86%, | 9.4779 million | , 2.777 billion |
| 603259 | WuXi AppTec | 9.50% | 39.19 million | 2.052 billion |
| 600436 | Pien Tze Huang | 5.65% | 4.7161 trillion | 1.219 billion |
| 300015 | Aier Ophthalmology | 5.37% | 72.8278 million | 1.159 billion |
| 000538 | Yunnan Baiyao | 3.93% | 13.9282 trillion | 850 million |
| 688271 | United Imaging Medical | 3.08%, | 5,201,706,666 | million |
| 002252 | Shanghai RAAS | 3.04%, | 83,027,000,656 | million |
| 002001 | Xinhecheng | 3.03% | 28.9604 trillion | 654 million |
| 300122 | Zhifei Biotech | 2.89% | 18.6942 | trillion.624 billion |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
